New Clozapine Data Suggest FDA Should Ease Restrictions

The risk for severe neutropenia with clozapine is minimal, suggesting that burdensome FDA-required hematologic monitoring should be relaxed, researchers said.
Medscape Medical News

source https://www.medscape.com/viewarticle/new-clozapine-data-suggest-fda-should-ease-onerous-2024a100096l?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?